Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | RAD52 | P43351 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | GRM2 | Q14416 | 3/20 | 0.33 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27630413 | 1.00 | EPHX1 (0.61) | EPHX1ALDH1A1CYP1A2RAD52PPARG | |
| SCHEMBL5707836 | 1.00 | EPHX1 (0.61) | EPHX1ALDH1A1CYP1A2RAD52PPARG | |
| SCHEMBL17781896 | 1.00 | EPHX1 (0.61) | EPHX1ALDH1A1CYP1A2RAD52PPARG | |
| SCHEMBL28757033 | 1.00 | EPHX1 (0.61) | EPHX1ALDH1A1CYP1A2RAD52PPARG | |
| SCHEMBL14130542 | 1.00 | EPHX1 (0.61) | EPHX1ALDH1A1CYP1A2RAD52PPARG | |
| SCHEMBL11631752 | 1.00 | EPHX1 (0.61) | EPHX1ALDH1A1CYP1A2RAD52PPARG | |
| SCHEMBL20576664 | 1.00 | EPHX1 (0.61) | EPHX1ALDH1A1CYP1A2RAD52PPARG | |
| SCHEMBL20576991 | 1.00 | EPHX1 (0.61) | EPHX1ALDH1A1CYP1A2RAD52PPARG | |
| SCHEMBL20576276 | 1.00 | EPHX1 (0.61) | EPHX1ALDH1A1CYP1A2RAD52PPARG | |
| SCHEMBL11664853 | 0.98 | EPHX1 (0.57) | EPHX1ALDH1A1CYP1A2RAD52PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 361 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4607278-A1 | CHEMICALLY-AMPLIFIED POSITIVE PHOTORESIST COMPOSITION FOR PATTERN PROFILE IMPROVEMENT AND ETCH RESISTANCE ENHANCEMENT | Ycchem Co., Ltd. (KR) | 2025-08-27 | — | — | EP | claimed |
| US-20250199405-A1 | CHEMICALLY-AMPLIFIED POSITIVE PHOTORESIST COMPOSITION FOR PATTERN PROFILE IMPROVEMENT AND ETCH RESISTANCE ENHANCEMENT | YCCHEM CO., LTD. (KR) | 2025-06-19 | — | — | US | claimed |
| CN-107405356-B | Nucleotide phosphoramidate formulations | 美迪维尔公司 | 2020-08-04 | — | — | CN | claimed |
| CN-111265540-A | Nucleotide phosphoramidate formulations | 美迪维尔公司 | 2020-06-12 | — | — | CN | claimed |
| US-7378214-B2 | Preparation method of toner having micro radius | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-05-27 | — | — | US | claimed |
| EP-1331927-B1 | TOPICAL COMPOSITION CONTAINING AT LEAST ONE VITAMIN D OR ONE VITAMIN D ANALOGUE AND AT LEAST ONE CORTICOSTEROID | LEO PHARMA AS (DK) | 2007-12-12 | — | — | EP | claimed |
| US-20050271970-A1 | Preparation method of toner having micro radius | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2005-12-08 | — | — | US | claimed |
| US-20050234189-A1 | Preparation method of latex polymer comprising wax and colorant | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2005-10-20 | — | — | US | claimed |
| EP-0487958-B1 | Transparent or semi-transparent cosmetic composition | KAO CORP (JP) | 1999-10-20 | — | — | EP | claimed |
| US-4393076-A | KETOPROFEN | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 1983-07-12 | — | — | US | claimed |
| US-4086090-A | PHOTORESIST LAYER, MASKING, PHOSPHOR SCREEN FOR COLOR PICTURE TUBE | HITACHI, LTD. (JA) | 1978-04-25 | — | — | US | claimed |
| JP-7053324-A | — | — | None | — | — | JP | disclosed |
| US-12624126-B2 | Dextran-alpha-glucan graft copolymers and derivatives thereof | Nutrition & Biosciences USA 4, Inc. (US) | 2026-05-12 | — | — | US | disclosed |
| EP-4426888-B1 | COMPOSITIONS COMPRISING ONE CATIONIC ALPHA-1,6-GLUCAN DERIVATIVE AND ONE ALPHA-1,3-GLUCAN | NUTRITION & BIOSCIENCES USA 4 INC (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20250339361-A1 | COMPOSITIONS COMPRISING XANTHAN GUM AND CRYSTALLINE ALPHA-1,3-GLUCAN | NUTRITION & BIOSCIENCES USA 4 INC (US) | 2025-11-06 | — | — | US | disclosed |
| EP-0124186-A2 | Imidazole-ethanol esters | GIST-BROCADES N.V. (NL) | 1984-11-07 | — | — | EP | disclosed |
| US-4393076-A | KETOPROFEN | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 1983-07-12 | — | — | US | disclosed |
| US-4086090-A | PHOTORESIST LAYER, MASKING, PHOSPHOR SCREEN FOR COLOR PICTURE TUBE | HITACHI, LTD. (JA) | 1978-04-25 | — | — | US | disclosed |
| US-4029625-A | Non-phasing chloroprene polymer adhesive composition and preparation thereof | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JA) | 1977-06-14 | — | — | US | disclosed |
| US-3941738-A | Non-phasing chloroprene polymer adhesive composition and preparation thereof | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JA) | 1976-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624126-B2 | Dextran-alpha-glucan graft copolymers and derivatives thereof | ALG8, DDOST, ALG1 | EPHX1 3552/4885ALDH1A1 1366/4885CYP1A2 2620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.